Sanofi forms strategic partnership with Cheplapharm regarding mature medicines
1 report, 1 independent
Updated Sep 21
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Sanofi announced a strategic partnership with Cheplapharm, which builds on collaborations that began in 2014. Under the agreement, Cheplapharm will take over 20 mature medicines and three manufacturing sites worldwide. In return, Sanofi will gain a 26.4% equity stake in Cheplapharm.
From pharmatimes.com
Why it matters
The partnership reflects a shared view that innovative and mature medicines require different operating models to meet commercial and regulatory needs. For Sanofi, the move allows the company to focus on innovation while ensuring essential medicines continue to reach patients.
From pharmatimes.com
Who's involved
- SanofiFrench pharmaceutical company participating in the strategic partnership